Home • News
The number of new referrals for patients with pulmonary hypertension has increased by over a fifth during the last five years, according to the latest National Audit report.
The aim of this study is to set up a UK and Ireland cohort of patients with idiopathic and heritable pulmonary arterial pulmonary hypertension (PAH) for research into the causes and potential treatments of this condition.
Howard Betts is running a Spring Concert Event to raise money for the PHA UK. It is to be held at the Little Wenlock Village Hall, Telford, on Saturday the 26th April, 2016.
PH patients – we need you! This is your chance to help strengthen the voice of PH patients and make sure we are heard loud and clear in future debates about NHS policy and spending reviews.
NHS England has launched a 30 day public consultation on a proposed number of new products to include Selexipag and Riociguat in the treatment of Pulmonary Arterial Hypertension.
The Pulmonary Hypertension Association (PHA UK) is in its 15th year. As the only charity to specifically support those with PH, we are undertaking a piece of work to understand and evaluate the contribution we make.